When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - Acceleron's ACE-083 an Orphan Drug for inherited neurological disorder
Acceleron Pharma Inc.
The FDA designates Acceleron Pharma's (NASDAQ:XLRN) Fast Track-tagged ACE-083 an Orphan Drug for the treatment of Charcot-Marie-Tooth disease, an inherited neurological disorder characterized by the progressive loss of muscle tissue and touch sensation due to peripheral nerve damage.
More news on: Acceleron Pharma Inc., Healthcare stocks news,